Delivery Order SPE2DB22D1106-SPE2DB25FEZA5
Award Date 7/22/25
Potential Completion Date 8/12/25
Potential Value $6.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $7,263.62 to AmerisourceBergen Drug Corp for the supply of XEOMIN 200 Unit Vials, with an ultimate completion date of August 13, 2025. This firm fixed price delivery order, issued on July 23, 2025, was competitively awarded without a set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a $46,934.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of XEOMIN 200 unit vials, with an ultimate completion date of August 12, 2025. This non-set-aside contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was competitively selected to fulfill this medical...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for XEOMIN 100 Unit vials with a ceiling value of $8,381.10. This firm fixed price delivery order, with an ultimate completion date of August 6, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) valued at $999,999,999.00 through December 2026. The award was made on a competitive basis with no set-aside designation,...
- The U.S. Defense Logistics Agency (DLA) awarded a $10,687.50 firm-fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of 4,565,833,076 units of the pharmaceutical product XEOMIN 50 UNIT VIALS. This delivery order has an ultimate completion date of October 4, 2024. AmerisourceBergen is a major pharmaceutical distributor that provides a wide range of medical commodities to federal agencies. This award appears to be part of a larger Indefinite Delivery Contract (IDC) with the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $24,639.28 firm-fixed-price contract is for the supply of 4,565,970,488 units of the pharmaceutical product XEOMIN 100 UNIT VIALS. The order has an ultimate completion date of October 18, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts by the DLA and other agencies to provide a wide range of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,117.48 to AmerisourceBergen Drug Corp for 100-unit vials of XEOMIN on July 28, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price contract represents a non-competitive set-aside and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a $11,174.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Xeomin 200 Unit Vials, with completion scheduled for August 8, 2025. This competitively awarded contract, issued without set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, to provide XEOMIN 100 unit vials. The award has a potential value of $1,572.72 and a completion date of January 31, 2024. Amerisourcebergen Drug Corporation is a prime contractor that has received numerous federal contract awards from DLA to supply pharmaceuticals, medical supplies, and related distribution services in...
- This is a $93,868.32 firm fixed-price delivery order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of 4,568,803,219 units of the pharmaceutical product XEOMIN 200. The delivery order is not set aside and has an ultimate completion date of August 5, 2025. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,609,982 units of the pharmaceutical product XEOMIN 100 Unit Vials. The contract has a potential value of $7,715.88 and a completion date of March 1, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside designation. Amerisourcebergen Drug Corp also...